サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291616

静注療法および静脈アクセス市場：タイプ別、用途別、地域別、2023-2028年

Intravenous Therapy and Vein Access Market by Type, Applications, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
静注療法および静脈アクセス市場：タイプ別、用途別、地域別、2023-2028年
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の静注療法および静脈アクセスの市場規模は、2022年に238億5,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.31%の成長率（CAGR）を示し、2028年までに328億3,000万米ドルに達すると予測しています。慢性疾患の蔓延、交通事故の増加、静脈内治療の利点に関する消費者の意識の高まりが、市場を牽引する主要因の一部となっています。

静脈内療法は、静脈を通じて血液中に直接、水分、薬物、栄養を投与する医療行為です。この手法は、病院やクリニックなどのヘルスケア施設で、さまざまな症状や病気を治療するために一般的に使用されています。静脈アクセスとは、点滴治療を行うために静脈に入るプロセスのことです。医療従事者は通常、針を使用して皮膚を穿刺し、静脈にアクセスしますが、静脈が小さい、または損傷している、脱水、肥満などの要因により、一部の患者さんでは困難な場合があります。点滴治療には、脱水症状に対する生理食塩水、感染症に対する抗生物質、がん治療に対する化学療法など、いくつかの種類があります。また、病気の治療だけでなく、予防接種やビタミンの摂取など、予防的な意味合いも含めて、点滴療法を行うこともあります。

静注療法および静脈アクセス市場の動向：

がん、糖尿病、自己免疫疾患など、長期的な投薬やモニタリングを必要とする慢性疾患や生活習慣病の有病率の増加が、主に静注療法および静脈アクセスの世界市場の成長を牽引しています。このほか、交通事故の増加や外傷の急増も市場成長に寄与しています。さらに、静注療法および静脈アクセスの利点に関する消費者の意識の高まりと、クリティカルケア治療の増加が、市場にとって有益な成長機会をもたらしています。また、低侵襲治療への嗜好の変化も、重要な成長促進要因となっています。さらに、必要な時間と労力を削減し、感染症のリスクを低減し、処置の精度を向上させるヘルスケア産業における数々の技術的進歩が、市場に明るい展望をもたらしています。また、新しい治療法、医薬品、医療機器の開発を目的とした研究開発への投資が、市場の拡大に寄与しています。さらに、医療費の増加、病院数の増加、在宅医療の普及、高齢者人口の増加が、市場の成長を促進しています。

本レポートで回答した主な質問

  • 世界の静注療法および静脈アクセス市場はこれまでどのように推移し、今後数年間はどのように推移するのでしょうか？
  • 世界の静注療法および静脈アクセス市場における市場促進要因、抑制要因、および機会は何か？
  • 各駆動要因、抑制要因、機会が世界の静注療法および静脈アクセス市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な静注療法および静脈アクセス市場を形成している国はどこか？
  • タイプ別の市場内訳は？
  • 静注療法および静脈アクセス市場において最も魅力的なタイプは何か？
  • 用途に基づく市場の内訳は？
  • 静注療法および静脈アクセス市場で最も魅力的な用途は？
  • エンドユーザーに基づく市場の内訳は？
  • 静注療法および静脈アクセス市場において最も魅力的なエンドユーザーはどこか？
  • 世界の静注療法および静脈アクセス市場の競争構造は？
  • 世界の静注療法および静脈アクセス市場の主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 世界の静注療法および静脈アクセス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • インプランタブルポート
    • 市場動向
    • 市場予測
  • 静脈内カテーテル
    • 市場動向
    • 市場予測
  • 皮下注射針
    • 市場動向
    • 市場予測
  • 輸液ポンプ
    • 市場動向
    • 市場展望
  • その他
    • 市場動向
    • 市場予測

第7章 用途別市場内訳

  • 栄養剤・緩衝液
    • 市場動向
    • 市場予測
  • 増量剤
    • 市場動向
    • 市場予測
  • 投薬管理
    • 市場動向
    • 市場予測
  • 血液ベース製品
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 バリューチェーン分析ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AngioDynamics Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • Medtronic plc
    • Tekni-Plex Inc.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS

本レポートに掲載されている企業名は一部であり、全企業名は本レポートに掲載されています。

図表

List of Figures

  • Figure 1: Global: Intravenous Therapy and Vein Access Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Therapy and Vein Access Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Intravenous Therapy and Vein Access Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Intravenous Therapy and Vein Access Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Intravenous Therapy and Vein Access Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Intravenous Therapy and Vein Access Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Intravenous Therapy and Vein Access (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Intravenous Therapy and Vein Access (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Intravenous Therapy and Vein Access (Nutrition And Buffer Solution) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Intravenous Therapy and Vein Access (Nutrition And Buffer Solution) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Intravenous Therapy and Vein Access (Volume Expander) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Intravenous Therapy and Vein Access (Volume Expander) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Intravenous Therapy and Vein Access (Medication Administration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Intravenous Therapy and Vein Access (Medication Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Intravenous Therapy and Vein Access (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Intravenous Therapy and Vein Access (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Intravenous Therapy and Vein Access (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Intravenous Therapy and Vein Access (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Intravenous Therapy and Vein Access Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Intravenous Therapy and Vein Access Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Intravenous Therapy and Vein Access Industry: Value Chain Analysis
  • Figure 83: Global: Intravenous Therapy and Vein Access Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Therapy and Vein Access Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Intravenous Therapy and Vein Access Market: Competitive Structure
  • Table 7: Global: Intravenous Therapy and Vein Access Market: Key Players
目次
Product Code: SR112023A7524

Market Overview:

The global intravenous (IV) therapy and vein access market size reached US$ 23.85 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.83 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

Intravenous (IV) Therapy and Vein Access Market Trends:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) therapy and vein access market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, application, and end user.

Type Insights:

  • Implantable Ports
  • Intravenous Catheters
  • Hypodermic Needles
  • Infusion Pumps
  • Others

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the type. This includes implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and others. According to the report, intravenous catheters represented the largest segment.

Application Insights:

  • Nutrition And Buffer Solution
  • Volume Expander
  • Medication Administration
  • Blood Based Products

A detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the application has also been provided in the report. This includes nutrition and buffer solution, volume expander, medication administration, and blood-based products. According to the report, medication administration accounted for the largest market share.

End User Insights:

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the end user. This includes hospitals, ambulatory surgical centers, and clinics. According to the report, hospitals represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global intravenous (IV) therapy and vein access market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global intravenous (IV) therapy and vein access market?
  • What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) therapy and vein access market?
  • What are the key regional markets?
  • Which countries represent the most attractive intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the intravenous (IV) therapy and vein access market?
  • What is the competitive structure of the global intravenous (IV) therapy and vein access market?
  • Who are the key players/companies in the global intravenous (IV) therapy and vein access market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Therapy and Vein Access Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable Ports
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravenous Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hypodermic Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infusion Pumps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Nutrition And Buffer Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Volume Expander
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medication Administration
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Blood Based Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius SE & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICU Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tekni-Plex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vygon SAS
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.